Management of Blood Pressure Control: At the Cutting Edge - European Medical Journal

Continue

Management of Blood Pressure Control: At the Cutting Edge

Cardiology
Download PDF

This satellite symposium took place on 29th August 2015  as a part of the European Society of Cardiology Congress 2015 in London, UK

Chairpeople:
Bryan Williams,1 Gianfranco Parati2
Speakers:
Thomas W. Weiss,3 Jean-Jacques Mourad,4 Massimo Volpe5

1. Institute of Cardiovascular Science, University College London, London, UK
2. St Luca Hospital, Istituto Auxologico Italiano, Milan, Italy
3. 3rd Medical Department, Wilhelminenhospital, Vienna, Austria
4. Avicenne University Hospital, AP-HP, Bobigny, France
5. University of Rome ‘La Sapienza’, Sant’Andrea Hospital, Rome, Italy

Disclosure:

Bryan Williams has received honoraria for lectures on hypertension from Daiichi Sankyo and  the Menarini Group. Gianfranco Parati has received honoraria for lecturing from Pfizer, Daiichi Sankyo, and Servier. Thomas W. Weiss has received lecture fees from AstraZeneca, Bayer, Boehringer Ingelheim,  Daiichi Sankyo, Eli Lilly, Medtronic, the Menarini Group, Novartis, Servier, and Vifor Pharma; advisory board and consultation fees from Abbot Vascular, AstraZeneca, Boston Scientific, Daiichi Sankyo, Eli Lilly,  Medtronic, and Sanofi Aventis; and research grants from AstraZeneca, the Austrian Science Fund, the  Austrian Cardiology Society, the Austrian Hypertension League, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, ISFP, the Menarini Group, and the Stein Erik Hagen Foundation. Jean-Jacques Mourad has received consultancy fees from Daiichi Sankyo, the Menarini Group, Servier, and Bristol-Myers Squibb. Massimo Volpe has received grants from the University of Rome Sapienza and the PRIN Italian Ministry of Health; has sat on speakers’ bureaux for Menarini International and Daiichi Sankyo Europe; and has acted  as a consultant and/or sat on advisory boards for Takeda International, Daiichi Sankyo Europe, Actelion,  and Novartis Pharma.

Acknowledgements:

Writing assistance was provided by Dr Lynda McEvoy of ApotheCom.

Support:

The symposium was jointly sponsored by Daiichi Sankyo and the Menarini Group. Authors  received honoraria for preparation and delivery of their presentations. The views and opinions expressed  are those of the authors and not necessarily of Daiichi Sankyo or the Menarini Group.

Citation:
EMJ Cardiol. ;3[Suppl 4]:10-17. DOI/10.33590/emjcardiol/10311935. https://doi.org/10.33590/emjcardiol/10311935.
Keywords:
European Society of Cardiology Congress

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.

Meeting Summary

Prof Williams opened the symposium by discussing the current state of blood pressure (BP) control in Europe and the key barriers to improving BP control rates. Prof Weiss presented the ‘Low BP in Vienna’ initiative that has been initiated in Austria in order to improve BP control. Prof Mourad discussed the  ongoing campaign to improve BP control rates in France, and Prof Volpe presented a case study of an elderly patient with hypertension and chronic kidney disease (CKD). Prof Parati concluded the symposium by commenting on the improvements in technology with respect to BP control.

The meeting objectives were to review the current achievement of BP goals in Europe since 2008; to evaluate the 70% BP goal initiatives in France and Italy; to use practical examples to assess the use  of single-pill fixed-dose combinations (FDCs); and to assess the impact of technological advances on  BP control.

Please view the full content in the PDF above. 

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.

Thank you!

Please share some more information on the rating you have given